Literature DB >> 28135561

Focal Cortical Dysplasia: Gene Mutations, Cell Signaling, and Therapeutic Implications.

Philip H Iffland1, Peter B Crino2.   

Abstract

Focal cortical dysplasias (FCDs) are malformations of cortical development (MCDs) that are highly associated with medication-resistant epilepsy and are the most common cause of neocortical epilepsy in children. FCDs are a heterogeneous group of developmental disorders caused by germline or somatic mutations that occur in genes regulating the PI3K/Akt/mTOR pathway-a key pathway in neuronal growth and migration. Accordingly, FCDs are characterized by abnormal cortical lamination, cell morphology (e.g., cytomegaly), and cellular polarity. In some FCD subtypes, balloon cells express proteins typically seen in neuroglial progenitor cells. Because recurrent intractable seizures are a common feature of FCDs, epileptogenic electrophysiological properties are also observed in addition to local inflammation. Here, we will summarize the current literature regarding FCDs, addressing the current classification system, histopathology, molecular genetics, electrophysiology, and transcriptome and cell signaling changes.

Entities:  

Keywords:  developmental biology; focal cortical dysplasia electrophysiology; inflammation; mTOR; mTORopathy; molecular genetics; transcriptome

Mesh:

Year:  2017        PMID: 28135561     DOI: 10.1146/annurev-pathol-052016-100138

Source DB:  PubMed          Journal:  Annu Rev Pathol        ISSN: 1553-4006            Impact factor:   23.472


  36 in total

1.  The mTOR pathway in treatment of epilepsy: a clinical update.

Authors:  Jennifer L Griffith; Michael Wong
Journal:  Future Neurol       Date:  2018-05-29

2.  Neuroinflammatory Nexus of Pediatric Epilepsy.

Authors:  Shruti Bagla; Alan A Dombkowski
Journal:  J Pediatr Epilepsy       Date:  2018-09-03

Review 3.  The role of somatic mutational events in the pathogenesis of epilepsy.

Authors:  Philip H Iffland; Peter B Crino
Journal:  Curr Opin Neurol       Date:  2019-04       Impact factor: 5.710

4.  Defining the latent period of epileptogenesis and epileptogenic zone in a focal cortical dysplasia type II (FCDII) rat model.

Authors:  Hsin-Yi Kao; Shuntong Hu; Temenuzhka Mihaylova; Julie Ziobro; EunSeon Ahn; Carli Fine; David Brang; Brendon O Watson; Yu Wang
Journal:  Epilepsia       Date:  2021-03-18       Impact factor: 5.864

5.  A connectome-based mechanistic model of focal cortical dysplasia.

Authors:  Seok-Jun Hong; Hyo-Min Lee; Ravnoor Gill; Joelle Crane; Viviane Sziklas; Boris C Bernhardt; Neda Bernasconi; Andrea Bernasconi
Journal:  Brain       Date:  2019-03-01       Impact factor: 13.501

6.  mTOR Hyperactivity Levels Influence the Severity of Epilepsy and Associated Neuropathology in an Experimental Model of Tuberous Sclerosis Complex and Focal Cortical Dysplasia.

Authors:  Lena H Nguyen; Travorn Mahadeo; Angélique Bordey
Journal:  J Neurosci       Date:  2019-01-30       Impact factor: 6.167

7.  Somatic Depdc5 deletion recapitulates electroclinical features of human focal cortical dysplasia type IIA.

Authors:  Shuntong Hu; Robert C Knowlton; Brendon O Watson; Katarzyna M Glanowska; Geoffrey G Murphy; Jack M Parent; Yu Wang
Journal:  Ann Neurol       Date:  2018-08-06       Impact factor: 10.422

8.  DEPDC5 and NPRL3 modulate cell size, filopodial outgrowth, and localization of mTOR in neural progenitor cells and neurons.

Authors:  Philip H Iffland; Marianna Baybis; Allan E Barnes; Richard J Leventer; Paul J Lockhart; Peter B Crino
Journal:  Neurobiol Dis       Date:  2018-02-24       Impact factor: 5.996

9.  Dynamic analysis of 4E-BP1 phosphorylation in neurons with Tsc2 or Depdc5 knockout.

Authors:  Philip H Iffland; Allan E Barnes; Marianna Baybis; Peter B Crino
Journal:  Exp Neurol       Date:  2020-08-08       Impact factor: 5.330

10.  A PIK3R2 Mutation in Familial Temporal Lobe Epilepsy as a Possible Pathogenic Variant.

Authors:  Yishu Wang; Jing Peng; Shuwei Bai; Haojun Yu; Hong He; Chunxiang Fan; Yong Hao; Yangtai Guan
Journal:  Front Genet       Date:  2021-05-10       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.